Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with lung cancer, confirmed through tissue testing and imaging scans
- People who are older than 18 years of age
- People who have already received a type of chemotherapy that contains platinum
- People whose doctors estimate they are expected to live for at least six months
Who may not be able to join:
- People who would have difficulty taking a supplement on a consistent, timely schedule
- People whose recent blood tests (taken within the past 14 days) show that the liver or kidneys are not functioning normally
- People who have had an unexplained fever of 38.5°C or higher lasting 7 days in a row, or ongoing diarrhea lasting 15 days in a row, within the past 30 days
- People who are currently receiving hormone therapy
- People who have a significant heart condition or irregular heartbeat that the treating doctor considers serious enough to make trial participation unsuitable
- People who have a significant nerve or nervous system disorder
- People who currently have an active infection
- People who have a known allergy or allergic reaction to the trial product or any of its ingredients
- People who are currently taking any supplements that contain an extract from the fungus Antrodia camphorata
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 886-2-8792-3311
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Nausea and vomiting; Sleep quality; Symptom assessment; Overall quality of life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.